About

President, Chief Executive Officer, Executive Chairman of the Board

Over 25 years of experience in the pharmaceutical industry.
Former President, CEO, and Director of Mind Medicine Inc. (NEO:MMED). Mind Medicine was the first psychedelics company to list on a stock exchange.
Former President & CEO of Cipher Pharmaceuticals Inc. (TSX:CPH). Expanded the product pipeline with seven business development transactions that restored the company to positive EBITDA.
Former President of Watson Pharmaceuticals Canada.
Led integration of major mergers and acquisitions, including Warner Chilcott (~$5B global acquisition), Forest Laboratories (~$28B global acquisition), and Allergan ($66B global acquisition).
Former VP, General Manager Celgene US Inﬂammation & Immunology.

Chief Financial Officer

Former CFO of Better Plant Sciences Inc. (CSE: PLNT).
Serves as Chair of the Audit Committee for Datable Technology Corp. (TSXV: TTM) since 2015.
Former CFO of Hanwei Energy Services Corp. (TSX: HE).
Former Chair of Governance and member of Audit Committees at Poydras Gaming Finance Corp. (TSXV: PYD).
Designated CPA, CGA.

Consultant

Over 15 years of development and commercialization experience in leading Canadian biopharma and diagnostic companies from preclinical development to product management.
Developed and successfully launched innovative medical services at Canada’s largest diagnostic provider, LifeLabs, focused on client needs and improved patient outcomes.
Success in corporate development, including pivotal roles in licensing, M&A, and capital raises at Therapure Biopharma Inc. (now Resilience Biotechnologies Inc) and Cipher Pharmaceuticals Inc. (TSX:CPH).
Ph.D. from Western University.